(Q70212917)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2060543%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

title

Comparative studies on the influence of different fibrates on serum lipoproteins in endogenous hyperlipoproteinaemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2060543%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

author name string

L Kłosiewicz-Latoszek

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2060543%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

W B Szostak

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2060543%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

publication date

1 January 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2060543%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Pharmacology

9 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2060543%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

volume

40

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2060543%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2060543%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

page(s)

33-41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2060543%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00315136

9 October 2019

exact match

0 references

cites work

Comparison of gemfibrozil and clofibrate on serum lipids in familial combined hyperlipidemia. A randomized placebo-controlled, double-blind, crossover clinical trial

1 reference

12 December 2020

Gel isoelectric focusing method for specific diagnosis of familial hyperlipoproteinemia type 3.

1 reference

12 December 2020

Bezafibrate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hyperlipidaemia

1 reference

12 December 2020

Lessons from the Helsinki Heart Study. Fibric acid therapy for dyslipidemia

1 reference

12 December 2020

Lipoprotein abnormalities in hypertriglyceridemia: significance in atherosclerosis

1 reference

12 December 2020

Change in very low-, low-, and high-density lipoproteins during lipid lowering (bezafibrate) therapy: studies in type IIA and type IIb hyperlipoproteinaemia

1 reference

12 December 2020

Lipoprotein fractionation

1 reference

12 December 2020

Fibric acids: effects on lipids and lipoprotein metabolism

1 reference

12 December 2020

Classification of hyperlipidaemias and hyperlipoproteinaemias

1 reference

12 December 2020

Influence of bezafibrate, fenofibrate, nicotinic acid and etofibrate on plasma high-density lipoprotein levels

1 reference

12 December 2020

Comparative toxicity and safety profile of fenofibrate and other fibric acid derivatives

1 reference

12 December 2020

Effects of bezafibrate on receptor-mediated and receptor-independent low density lipoprotein catabolism in type II hyperlipoproteinaemic subjects

1 reference

12 December 2020

Studies on mechanisms for enhanced clearance of low-density lipoproteins in patients with primary hypertriglyceridaemia

1 reference

12 December 2020

Abnormalities in very low, low and high density lipoproteins in hypertriglyceridemia. Reversal toward normal with bezafibrate treatment

1 reference

12 December 2020

Lipid-lowering drugs. An overview of indications and optimum therapeutic use.

1 reference

12 December 2020

Effects of fenofibrate on plasma lipoproteins in hypercholesterolemia and combined hyperlipidemia

1 reference

12 December 2020

Fenofibrate affects the compositions of lipoproteins

1 reference

12 December 2020

Comparative study of bezafibrate and fenofibrate in patients with primary hyperlipoproteinaemia

1 reference

12 December 2020

Effect of clofibrate and colestipol singly and in combination on plasma lipids and lipoproteins in type III hyperlipoproteinemia

1 reference

12 December 2020

The influence of clofibrate on lipid and protein components of very low density lipoproteins in type IV hyperlipoproteinaemia

1 reference

12 December 2020

Gemfibrozil therapy in primary hypertriglyceridemia associated with coronary heart disease. Effects on metabolism of low-density lipoproteins

1 reference

12 December 2020

Low density lipoproteins in atherosclerosis.

1 reference

12 December 2020

Apolipoprotein E phenotypes and hyperlipidemia

1 reference

12 December 2020

Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel

1 reference

12 December 2020

Gemfibrozil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in dyslipidaemia

1 reference

12 December 2020

Changes in lipoprotein kinetics during therapy with fenofibrate and other fibric acid derivatives

1 reference

12 December 2020

Fenofibrate reduces low density lipoprotein catabolism in hypertriglyceridemic subjects

1 reference

12 December 2020

Effect of fibric acid derivatives on blood lipid and lipoprotein levels

1 reference

12 December 2020

Influence of Gemfibrozil and Clofibrate on Metabolism of Cholesterol and Plasma Triglycerides in Man

1 reference

12 December 2020

Fenofibrate therapy of hypertriglyceridaemia. Differential effects on LDL cholesterol level in type IV and in type IIb primary hyperlipoproteinaemia

1 reference

12 December 2020

On the rise in low density and high density lipoproteins in response to the treatment of hypertriglyceridaemia in type IV and type V hyperlipoproteinaemias

1 reference

12 December 2020

Influence of bezafibrate and colestipol on LDL-cholesterol, LDL-apolipoprotein B and HDL-cholesterol in hyperlipoproteinaemia.

1 reference

12 December 2020

Combination drug therapy for familial combined hyperlipidemia

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00315136

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2060543%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

1 reference